More Than 30,000 Cholesterol Drugs Recalled Nationwide

More Than 30,000 Cholesterol Drugs Recalled Nationwide

More Than 30,000 Cholesterol Drugs Recalled Nationwide

Quick read below — save or share if useful.

More than 30,000 prescribed cholesterol drugs have recently been recalled nationwide, raising concerns for many Americans who rely on these medications to manage their cholesterol levels. Despite the importance of taking these drugs, only 50% of eligible Americans are actually following their prescribed regimens, according to a 2025 study from experts at Johns Hopkins. The U.S. Food and Drug Administration (FDA) recently issued two separate recall announcements that highlight potential issues with certain cholesterol medications. The first recall, announced on January 20, involves 7,991 cartons of 10-milligram Rosuvastatin tablets manufactured by AvKARE. Rosuvastatin is a medication commonly used to lower "bad" cholesterol (LDL) and triglycerides while boosting "good" cholesterol (HDL). The recall was initiated due to the tablets being out of specification for dissolution, which could affect how effectively the drug is absorbed by the body. The second recall, announced on January 22, affects 22,896 bottles of 1-gram Icosapent Ethyl capsules distributed by Zydus Pharmaceuticals (USA) Inc. Icosapent Ethyl capsules are prescribed to treat high triglyceride levels and may also be used to reduce the risk of heart attacks or strokes. The recall was initiated due to concerns about the capsules being subpotent, leading to inconsistent therapeutic effects and potential gastrointestinal side effects in some patients. Both recalls have been classified as Class II events by the FDA, indicating that they may cause temporary or medically reversible adverse health consequences, with a remote probability of serious adverse health effects. It is crucial for individuals who are prescribed these medications to check with their healthcare providers to determine if their specific medication is affected by the recalls. Patients should not stop taking their prescribed cholesterol medications without consulting a healthcare professional, as untreated high cholesterol can lead to serious health complications. In conclusion, the recent recalls of over 30,000 prescribed cholesterol drugs serve as a reminder of the importance of medication safety and adherence. Patients should stay informed about potential recalls and always follow their healthcare provider's guidance when it comes to managing their cholesterol levels. By staying vigilant and proactive, individuals can protect their health and well-being in the long run.
Follow & Connect
Explore My Other Blogs

Enjoyed this post? Share it or explore more across my blogs and channels.

Hi, I’m Ciro Irmici, an entrepreneur and investor from San Severo, Italy. My passions range from investments (stocks, crypto, dividends) to automation and creating businesses that help people. I believe in building things that matter, like a gym for all and a theatre for people to enjoy music. I love learning and sharing what I learn: how to create eBooks, audiobooks, and other digital products. I’m also deeply into fitness (gym, running, jump rope) and creativity (painting, music, design). My ultimate goal? To reach financial freedom and help others achieve their dreams.

Comments

Post a Comment